Jussi Sutinen

3.3k total citations
48 papers, 1.8k citations indexed

About

Jussi Sutinen is a scholar working on Emergency Medicine, Infectious Diseases and Virology. According to data from OpenAlex, Jussi Sutinen has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Emergency Medicine, 23 papers in Infectious Diseases and 22 papers in Virology. Recurrent topics in Jussi Sutinen's work include HIV-related health complications and treatments (35 papers), HIV Research and Treatment (22 papers) and HIV/AIDS drug development and treatment (13 papers). Jussi Sutinen is often cited by papers focused on HIV-related health complications and treatments (35 papers), HIV Research and Treatment (22 papers) and HIV/AIDS drug development and treatment (13 papers). Jussi Sutinen collaborates with scholars based in Finland, Sweden and Germany. Jussi Sutinen's co-authors include Hannele Yki‐Järvinen, Matti Ristola, Jukka Westerbacka, Anna‐Maija Häkkinen, Satu Vehkavaara, Elena Korsheninnikova, Anders Hamsten, Juha Halavaara, Anneli Seppälä‐Lindroos and Asko Järvinen and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Jussi Sutinen

48 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jussi Sutinen Finland 25 1.1k 754 606 503 263 48 1.8k
Julian Falutz Canada 27 1.3k 1.3× 857 1.1× 679 1.1× 536 1.1× 165 0.6× 79 2.2k
Tiziana Quirino Italy 22 557 0.5× 841 1.1× 493 0.8× 331 0.7× 188 0.7× 60 1.5k
Markus Bickel Germany 25 638 0.6× 1.1k 1.5× 657 1.1× 691 1.4× 119 0.5× 73 1.9k
M Pang China 15 777 0.7× 477 0.6× 381 0.6× 272 0.5× 102 0.4× 27 1.9k
Peter Jensen United States 12 571 0.5× 838 1.1× 515 0.8× 245 0.5× 111 0.4× 14 1.3k
Ana Milinkovic Spain 25 890 0.8× 1.4k 1.8× 771 1.3× 818 1.6× 143 0.5× 70 2.3k
Amie L. Meditz United States 23 169 0.2× 1.0k 1.4× 1.1k 1.8× 618 1.2× 99 0.4× 33 2.5k
Joel A. Dave South Africa 22 480 0.5× 537 0.7× 260 0.4× 413 0.8× 113 0.4× 65 1.4k
Chiara Stentarelli Italy 18 577 0.5× 353 0.5× 196 0.3× 358 0.7× 33 0.1× 34 977
Douglas Kitch United States 21 1.2k 1.2× 994 1.3× 678 1.1× 288 0.6× 50 0.2× 38 1.8k

Countries citing papers authored by Jussi Sutinen

Since Specialization
Citations

This map shows the geographic impact of Jussi Sutinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jussi Sutinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jussi Sutinen more than expected).

Fields of papers citing papers by Jussi Sutinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jussi Sutinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jussi Sutinen. The network helps show where Jussi Sutinen may publish in the future.

Co-authorship network of co-authors of Jussi Sutinen

This figure shows the co-authorship network connecting the top 25 collaborators of Jussi Sutinen. A scholar is included among the top collaborators of Jussi Sutinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jussi Sutinen. Jussi Sutinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ollgren, Jukka, Henrikki Brummer‐Korvenkontio, Kirsi Liitsola, et al.. (2025). Use of healthcare services preceding HIV diagnosis – missed opportunities for earlier diagnosis, Finland, 1996 to 2019. Eurosurveillance. 30(18). 1 indexed citations
2.
Aho, Inka, Olli Tynninen, Anu Suomalainen, et al.. (2024). Effect of 2 Forms of Tenofovir on Duodenal Enterocytes—A Hypothesis for Different Effect of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide on Body Weight and Plasma Lipids. Clinical Infectious Diseases. 80(2). 381–388. 2 indexed citations
3.
Lohiniva, Anna‐Leena, et al.. (2023). A qualitative study to identify thematic areas for HIV related patient-reported outcome measures (PROM) and patient-reported experience measures (PREM). Journal of Patient-Reported Outcomes. 7(1). 41–41. 2 indexed citations
4.
5.
Vuoti, S., Pia Kivelä, Perttu Arkkila, et al.. (2021). Liver Fat, Adipose Tissue, and Body Composition Changes After Switching from a Protease Inhibitor or Efavirenz to Raltegravir. AIDS Patient Care and STDs. 35(9). 335–341. 6 indexed citations
6.
Aho, Inka, Pia Kivelä, Jari Haukka, Jussi Sutinen, & Oskari Heikinheimo. (2017). Declining prevalence of cytological squamous intraepithelial lesions of the cervix among women living with well‐controlled HIV – Most women living with HIV do not need annual PAP smear screening. Acta Obstetricia Et Gynecologica Scandinavica. 96(11). 1330–1337. 8 indexed citations
7.
Pereira, Marco, et al.. (2017). Factors associated with the quality of life of people living with HIV in Finland. AIDS Care. 29(8). 1074–1078. 41 indexed citations
8.
Sutinen, Jussi & Matti Ristola. (2012). HIV - tappavasta taudista krooniseksi sairaudeksi. 128(1). 37–46. 2 indexed citations
9.
Sutinen, Jussi & Matti Ristola. (2012). [HIV--from a lethal disease to a chronic illness].. PubMed. 128(1). 37–46. 2 indexed citations
10.
Raboud, Janet, Christina Diong, Andrew Carr, et al.. (2010). A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy. HIV Clinical Trials. 11(1). 39–50. 26 indexed citations
11.
Sutinen, Jussi. (2008). The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV‐Infected Patients. PPAR Research. 2009(1). 373524–373524. 22 indexed citations
12.
Makkonen, Janne, Jukka Westerbacka, Maria Kolak, et al.. (2007). Increased expression of the macrophage markers and of 11β-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity. International Journal of Obesity. 31(10). 1617–1625. 34 indexed citations
13.
Sutinen, Jussi & Hannele Yki‐Järvinen. (2006). Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy. American Journal of Physiology-Endocrinology and Metabolism. 292(3). E687–E692. 43 indexed citations
14.
Sutinen, Jussi, et al.. (2005). Uridine supplementation increases subcutaneous fat in patients with HAART-associated lipodystrophy: a randomized, placebo-controlled trial. Antiviral Therapy. 10. 9 indexed citations
15.
Sevastianova, Ksenia, Jussi Sutinen, Jukka Westerbacka, Matti Ristola, & Hannele Yki‐Järvinen. (2005). Arterial Stiffness in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy. Antiviral Therapy. 10(8). 925–935. 41 indexed citations
16.
Pietiläinen, Kirsi H., Aila Rissanen, Jaakko Kaprio, et al.. (2004). Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. American Journal of Physiology-Endocrinology and Metabolism. 288(4). E768–E774. 79 indexed citations
17.
Sutinen, Jussi, Katja Kannisto, Elena Korsheninnikova, et al.. (2004). Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. American Journal of Physiology-Endocrinology and Metabolism. 286(6). E941–E949. 45 indexed citations
18.
Sutinen, Jussi, Anna‐Maija Häkkinen, Jukka Westerbacka, et al.. (2003). Rosiglitazone in the Treatment of Haart-Associated Lipodystrophy – a Randomized Double-Blind Placebo-Controlled Study. Antiviral Therapy. 8(3). 199–207. 149 indexed citations
19.
Sutinen, Jussi, Matti Ristola, Jukka Suni, Hannu Nuutinen, & Juhani Lähdevirta. (1999). Severe Neutropenia During Therapy for Concurrent Primary Human Immunodeficiency Virus and Cytomegalovirus Infections. Clinical Infectious Diseases. 28(4). 920–921. 2 indexed citations
20.
Leino, Tuija, Pauli Leinikki, Timo Hyypiä, et al.. (1997). Hepatitis A Outbreak Amongst Intravenous Amphetamine Abusers in Finland. Scandinavian Journal of Infectious Diseases. 29(3). 213–216. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julian Falutz Breakdown of academic impact, for papers by Tiziana Quirino Breakdown of academic impact, for papers by Markus Bickel Breakdown of academic impact, for papers by M Pang Breakdown of academic impact, for papers by Peter Jensen Breakdown of academic impact, for papers by Ana Milinkovic Breakdown of academic impact, for papers by Amie L. Meditz Breakdown of academic impact, for papers by Joel A. Dave Breakdown of academic impact, for papers by Chiara Stentarelli Breakdown of academic impact, for papers by Douglas Kitch
Rankless by CCL
2026